2024-09-10 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $1.23 | $9,839 | +7.94% | |
2024-05-08 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.04 | $25,000 | -31.28% | |
2023-11-20 | Sale | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $1.96 | $4,053 | +1.66% | |
2022-06-15 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $0.65 | $3,240 | -25% | |
2022-04-27 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $0.68 | $1,710 | -30.88% | |
2022-04-26 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $0.69 | $3,450 | -30.88% | |
2021-10-26 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $1.66 | $4,150 | -48.82% | |
2021-04-30 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.28 | $4,970 | -23.9% | |
2021-03-04 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.50 | $6,250 | -13.9% | |
2020-12-10 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $1.99 | $4,975 | +2.84% | |
2020-11-30 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.14 | $4,708 | +1.88% | |
2020-08-12 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.58 | $10,318 | -8.59% | |
2020-06-22 | Purchase | Plus Therapeutics, Inc. PSTV | Chief Executive Officer | | $2.10 | $10,500 | +7.81% | |
2015-08-28 | Purchase | Plus Therapeutics, Inc. PSTV | President and CEO | | $0.31 | $372 | -38.33% | |
2015-08-27 | Purchase | Plus Therapeutics, Inc. PSTV | President and CEO | | $0.31 | $3,052 | -34.11% | |
2015-08-21 | Purchase | Plus Therapeutics, Inc. PSTV | President and CEO | | $0.36 | $3,650 | -47.37% | |
2015-08-20 | Purchase | Plus Therapeutics, Inc. PSTV | President and CEO | | $0.40 | $4,000 | -47.37% | |
2015-08-18 | Purchase | Plus Therapeutics, Inc. PSTV | President and CEO | | $0.39 | $3,949 | -50% | |
2012-12-19 | Purchase | Plus Therapeutics, Inc. PSTV | President | | $2.85 | $28,500 | -9.17% | |
2011-12-14 | Purchase | Plus Therapeutics, Inc. PSTV | President | | $2.15 | $12,880 | +29.22% | |